In November 1994 after 15 years of epidemiologic silence, Ebola virus reemerged in Africa and, for the first time, in West Africa. In Cô te d'Ivoire, a 34-year-old female ethologist was infected while conducting a necropsy on a wild chimpanzee. Eight days later, the patient developed a syndrome that did not respond to antimalarial drugs and was characterized by high fever, headache, chills, myalgia, and cough. The patient had abdominal pain, diarrhea, vomiting, and a macular rash, and was repatriated to Switzerland. The patient suffered from prostration and weight loss but recovered without sequelae. Laboratory findings included aspartate aminotransferase and alanine aminotransferase activity highly elevated, thrombocytopenia, lymphopenia, and, subsequently, neutrophilia. A new subtype of Ebola was isolated from the patient's blood on days 4 and 8. No serologic conversion was detected among contact persons in Cô te d'Ivoire (n Å 22) or Switzerland (n Å 52), suggesting that infection-control precautions were satisfactory.
a Swiss Air Ambulance jet. During the flight, the patient wore after 6 weeks. A month after onset, her hair became dry, lost its elasticity, and began falling out in large quantities. Hair loss a mask, and the physician and nurse wore surgical masks, gloves, and gowns. Due to the geographic closeness of TaıF lasted Ç3 months. National Park to Liberia, it was considered that the patient might have Lassa fever.
Laboratory Investigation (Tables 1, 2 ) On day 8, the patient was admitted to the University Hospital of Basel. She was transferred to a single, double-door isolation Persistent thrombocytopenia and an early lymphopenia followed by neutrophilic hyperleukocytosis were observed. The room with negative pressure. All health care workers wore high-quality gloves, gowns, and dust-and-mist masks (3M coagulation profile and platelet counts evoked an intravascular coagulation. The most notable biochemical finding was highly Pharmaceuticals, St. Paul, MN). Because her illness started a week after the necropsy of a nonhuman primate, infectionelevated aspartate aminotransferase (AST) activity and alanine aminotransferase (ALT) activity. g-glutamyl transferase was control practice did comply with guidelines of the Centers for Disease Control and Prevention [13] . On admission, she was normal to slightly elevated, and alkaline phosphatase was normal to highly elevated. Creatinine kinase was slightly above tired but awake. Physical examination revealed tender spleen and liver on palpation. An ultrasound scan of the abdomen was normal on day 8 but normal thereafter. Lactate dehydrogenase was 20 times normal on day 7, and amylase levels increased normal. The differential diagnosis included a viral or bacterial infection of unknown origin, dengue fever, rickettsial disease, from day 11 to 14. As of day 15, all values progressively stabilized. hantavirus infection, leptospirosis, typhoid fever, and malaria. A form of hemorrhagic fever (Lassa fever or EBO virus) was
Results for tests for parasites in blood and stool, blood cultures, and cultures of urine were negative. Urine samples were considered as unlikely. The patient was treated intravenously with ciprofloxacin and doxycycline for suspected gram-negaexamined on days 5, 10, and 12: Hematuria was observed on day 5 and proteinuria on day 10. Electrolyte levels (sodium, tive sepsis, leptospirosis, or rickettsial disease.
On day 9, the patient became afebrile for 2 days. Therefore, potassium, calcium, phosphate) and lipid levels (triglycerides and cholesterol), which were investigated from day 7 to 14, clothes were disposed of as usual, using the double-bag technique, and used dishes were returned to the kitchen. On day 11, were normal. While the patient was in the Swiss hospital, serologic tests strict barrier isolation was reduced to body substance isolation practice. The same day, fever recurred. Diarrhea changed to for dengue fever, hantavirus, hepatitis B, C, and E, leptospirosis, Rickettsia mooseri, Rickettsia conorii, and brucelloconstipation, and the patient started to eat normally.
On day 15, she was discharged from the hospital, having sis were negative. She was IgG positive but IgM negative for Epstein-Barr and cytomegalovirus. Due to her lack of bleeding, lost 6 kg (10% of her initial weight). The patient fully recovered / 9d49$$se08
12-30-98 14:46:10 jinfa UC: J Infect tests for hemorrhagic fever (Lassa fever or EBO) had not been virus, and hantaviruses. Virus isolation was attempted on a patient serum sample obtained during the febrile phase of the required.
illness (26 November, day 3 of illness). A new EBO virus (subtype Cõte d'Ivoire; EBO-CI) was isoVirologic Investigation lated [11] . Antibody and antigen titers in serum samples obtained 3, 7, 22, 41, 81, 211, and 466 days after onset of illness were An epidemiologic investigation was done during the first determined by IFA and ELISA (table 3) . The IFA test was done days of December 1994 to determine the cause of deaths among using EBO-infected Vero E6 cells as described [15] . The IgG the community of chimpanzees being studied by the ethologist ELISA was done using Vero cell lysates as antigens as described who became ill (see [14] , in this supplement). The survey [16] . For the IgM capture assay, plates were coated with antiindicated a highly lethal epidemic with hemorrhagic syndrome. IgM sera overnight, and then diluted serum was added, followed Etiology was unknown, and differential diagnosis included a by specific and control antigen. Antigen fixation was revealed viral infection of unknown origin, anthrax, dengue, and African with anti-EBO rabbit serum and peroxidase-labeled anti-rabbit hemorrhagic fevers. A serologic survey was done among the serum. For the antigen detection test, we used the reagents and research workers, and 8 samples were collected. Thinking that technique described by Ksiazek et al. [17] . the case-patient could have been contaminated during the necThe other research workers were negative for EBO, includropsy, we asked the Ivoirian clinic for a serum sample from ing 2 who participated in the necropsy in which the case-patient the patient. Nine samples, including 1 from the case-patient, presumably was infected. All researchers (including the casewere sent to Institut Pasteur on 14 December. We asked for patient) had observed the chimpanzees, using noninvasive differential diagnostics, notably, anthrax, dengue, Crimeanmethods and avoiding all physical contact with them and keepCongo hemorrhagic fever (CCHF), Rift Valley fever, yellow fever, chikungunya, Lassa fever, EBO virus, Marburg (MBG) ing a minimum of 3 -4 m away from the animals.
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Mode of Contamination and Contact Persons
members of the air-rescue service, and the hospital and laboratory staff. No antibodies against EBO were found by ELISA The chimpanzee organs from the implicated necropsy were or IFA in any of the 74 sera tested. shown by immunohistochemistry to be infected with EBO [11] . During the necropsy, all 3 researchers had worn gloves but not masks or gowns. No wounds or punctures had been noted. Two Discussion researchers had worn latex examination gloves, but the casepatient had worn household gloves. Therefore, it is highly probThis is the first case of EBO hemorrhagic fever (EHF) reable that she became contaminated during the necropsy by ported in West Africa and the first documented human infection direct contact with chimpanzee blood on her hand or by projecassociated with naturally infected nonhuman primates in Aftion of droplets onto her face. This would indicate an 8-day rica. Although several EHF cases have been briefly described incubation period.
[6], only the English case investigated by Emond et al. [8] is Contact persons were defined as those having had direct well documented. Our patient is thus the second fully investiface-to-face contact with the patient either 2 days before onset gated case of EHF. of illness or during illness [18] . In Côte d'Ivoire, sera were
The clinical course, the length of the disease, and signs sampled from 18 contact persons and 4 laboratory technicians during the patient's convalescence are consistent with the nonwho handled the chimpanzee's organs. In Switzerland, 52 conlethal EHF described among Yambuku's survivors and with tacts were interviewed and serologically investigated. These the English patient (in [8] ). Loss of memory, central nervous contacts included 8 family members and friends, the 4 crew system disorders, and loss of hair during the convalescent phase were also reported in persons with EHF or other hemorrhagic fevers (MBG virus, Lassa fever, and Argentinean hemorrhagic Table 3 . Serum antigen and antibody titers against EBO-CI in a fever). Loss of weight is a constant feature of EHF, due to female ethologist who presumably became infected while doing a asthenia and anorexia and probably to a direct action of the necropsy on an infected chimpanzee.
virus on tumor necrosis factor production. Raised levels of transaminases but normal levels of g-gluta- fever, myalgia, headache, and nausea, the most predictive signs for EBO and MBG infections is abdominal pain, which is often Despite the lack of obvious bleeding, the patient presented with a hematologic profile consistent with an intravascular coagulaaccompanied by diarrhea and, for Lassa fever infection, chest pain and sore throat [24] . The hemorrhagic form of Rift Valley tion.
The patient's mild form of EBO disease may have been due fever infections represents õ10% of the cases and begins with jaundice. to the virus subtype, the mode of contamination, or the biologic response of the patient (or a combination of all three factors).
The case presented herein highlights the threat of importation of a disease by a sporadic case: Air travel allows viruses to But regarding the high mortality rate (25%) among chimpanzees [14] , EBO-CI has to be considered as potentially highly travel from continent to continent within hours. The Kikwit, Democratic Republic of the Congo, epidemic (recognized in pathogenic in humans.
Although containment measures were not always tight and May 1995) showed that EBO and other deadly viruses may kill people for months before an outbreak and its agent are there were no specific precautions taken during laboratory tests (blood specimens were not inactivated prior to analysis), no identified. Thus, as recommended by WHO, there is an urgent need to improve both national surveillance efforts and the casecondary cases appeared among the contacts. Contacts included a man who ate from the same plate as the patient on pacity of laboratories around the world to diagnose these emerging diseases [25] . day 1 and a woman who comforted her in Côte d'Ivoire. Transmission of EHF requires physical contact with a patient or During this investigation, cooperation between researchers with different specialties (i.e., physicians, biologists, veterinaricontact with blood or secretions, as described in 1976 [1, 2] and confirmed during the Kikwit outbreak [23] . Universal preans, and microbiologists) was essential for determining the case-patient's diagnosis. Further collaboration between these cautions and barrier nursing methods are effective in preventing cross-infection. Our hypothesis is that the patient contaminated disciplines will be necessary to improve surveillance and control of emerging infectious diseases. herself by simple contact with infected chimpanzee blood, but the exact route of transmission in this case is unknown.
This episode emphasizes the difficulty of diagnosing new
